Figur 1. Victoza (liraglutid)

Figur 1. Medelskillnad i HbA_1c ± 95 % CI, fas III-studier (LOCF, ITT dataset), liraglutid jämfört med placebo och aktiv kontroll.

1573: Liraglutid versus glimepirid (4).
1572: Liraglutid + metformin vs. placebo + metformin vs. glimepirid + metformin (3).
1436: Liraglutid + glimepirid vs. placebo + glimepirid vs. glimepirid + rosiglitazon (2).
1574: Liraglutid + metformin + rosiglitazon vs. placebo + metformin + rosiglitazon (5).
1697: Liraglutid + metformin + glimepirid vs. placebo + metformin + glimepirid vs. glargin + metformin + glimepirid (6).